By inhibiting the expression of TGFβ and Cox2 within the liver we may convert immunologically cold tumors to ‘hot’ tumors where effector T-cells can penetrate deeper into the tumor and improve the efficacy of immune checkpoint inhibitors (1,36). This evidence concerns the gene TGFB1 and neoplasm.